Sleep Apnea Devices Market Size, CAGR, Share, Trends, Growth | Report 2022-2030

According to Vision Research Reports, the Sleep Apnea Devices market size is expected to be worth around US$ 7.1 billion by 2030 from valued at US$ 3.10 billion in 2020, growing at a CAGR of 6.8% from 2022 to 2030.

Growth Factors

The global prevalence of obesity is estimated to reach 18.0% in men and 21.0% in women by 2025. This, in turn, is estimated to drive the market as more than half of the overweight or obese people suffer from Obstructive Sleep Apnea (OSA).

Moreover, the rising geriatric population due to increasing life expectancy is expected to impel the prevalence of OSA. Sleep disorders increase with age, which is one of the key factors for high market share. However, low awareness and consequent low penetration of sleep apnea equipment in developing and underdeveloped economies present lucrative growth opportunities to market participants.

Full Report is Ready | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37522

The outbreak of COVID-19 pandemic negatively impacted the growth of the medical equipment required to diagnose the disease. There was the temporary closure of physician practices, home medical equipment suppliers, and sleep clinics due to quarantine or government restrictions, to control the spread of COVID-19. This, in turn, has resulted in the decreased growth rate of diagnostic equipment during the COVID-19 related lockdowns.

However, sleep and respiratory care equipment witnessed a rapid increase in demand during the pandemic. The usage of PAP devices as an alternative to ventilators significantly increased the demand for PAP equipment. Moreover, a rise in adherence to PAP therapy for sleep apnea after the initial stages of the pandemic, as risk factors associated with COVID-19 are commonly present in the patients, positively impacted market growth.

The development of new technologies for the treatment and diagnosis of the disease is driving market growth. Moreover, new alternatives to CPAP equipment such as nasal and oral equipment are developed for patients with low CPAP tolerance. For instance, In February 2021, GoPAPFree, a homecare oral devices manufacturer for OSA, launched O2 Vent Optima to serve as an effective and more convenient CPAP alternative. This device increases sleep apnea therapy response by 40.0%. In February 2020, Fisher and Paykel launched F&P Evora with CapFit headgear, a compact nasal mask for treating sleep apnea. The company launched this product in the markets of New Zealand, Europe, Australia, and Canada.

Scope of the Report

Collaborative Agreements Help Innovate in Sleep Apnea Devices

Key players in the global sleep apnea devices market are engaged in meeting regulatory approvals, launching technologically advanced products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the sleep apnea devices market. Business expansion strategies adopted by players operating in the global sleep apnea devices market are innovating in 3D printed parts used to convert BiPAP (Bilevel Positive Airway Pressure) machines, generally used to treat sleep apnea or COPD, into ventilators.

Companies are entering into collaboration agreements to bring obstructive sleep apnea (OSA) treatment products directly to customers through sleep clinics in the U.S. They are introducing customizable oral appliance therapy devices, which hold potentials as an alternative to CPAP (continuous positive airway pressure) therapy in the U.S.

Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37522

eHealth Holds Potentials for Device Sales Post COVID-19 Pandemic

Telehealth and eHealth mobile apps are anticipated to transform the sleep apnea devices market post the COVID-19 pandemic period. However, participants in the market are addressing disruption for sales since elective medical procedures have been postponed indefinitely. Hence, companies are taking data-driven decisions to map volatile demand trends for sleep apnea devices.

Domestic and global companies are in the midst of rapid shift in supply chain planning, operations, and inventory management to address the impact of the pandemic. Nevertheless, companies are taking advantage of government stimulus packages to stay financially afloat. The demand for sleep apnea devices is projected to increase at a sluggish pace, due to the lockdown being enforced in most countries.

Lack of Insurance Coverage for Sleep Apnea Devices Hampers Market Growth

The most common treatment option for people with sleep apnea are CPAP devices. These machines are available in various sizes and styles. The price varies depending on the brand, type, and features. However, a CPAP machine can cost anywhere from US$ 250 to US$ 1,000 or more at retail. This is hampering market growth. Hence, companies should partner with experts to innovate in devices that are affordable.

On the other hand, in emerging markets such as India, the lack of medical coverage provided by public or private insurance companies tends to restrain the market growth in the region. Dearth of awareness about obstructive sleep apnea in emerging countries is expected to affect market growth during the forecast period. Hence, companies should focus on marketing sleep apnea devices to increase its acceptance, which, in turn, will encourage insurance companies to provide coverage for health issues pertaining to the OSA.

High Prevalence of Sleep Apnea Patients Contributes to Market Growth

Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80% of moderate and severe obstructive sleep apnea cases going undiagnosed. This is fueling the need of advertising on sleep apnea devices to make people aware about the serious health risks of OSA.

OSA, which accounts for the majority of cases, can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression, and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is diagnosed and treated. Thus, med-tech companies in the sleep apnea devices market should capitalize on this opportunity to bolster manufacturing capabilities to increase the availability of machines.

Health Risks of OSA Fueling Demand for Sleep Apnea Devices

Obstructive sleep apnea is a prevalent disease wherein people continuously halt or reduce their breathing while sleeping. This leads to restless, fragmented sleep, which could cause symptoms such as morning headaches and daytime lethargy.

OSA affects people of all ages; however, it is more common in people over the age of 60. The precise incidence is unknown; however, it is thought to be between 2% and 14%. Obstructive sleep apnea is linked to a number of health problems, including hypertension, coronary artery disease, cardiac arrhythmias, and depression. Obesity, one of the major sleep apnea risk factors, is on the rise, and contributes to the increase in prevalence of sleep apnea. Such trends are translating into revenue opportunities for med-tech companies in the sleep apnea devices market.

Report Highlights

The therapeutic devices segment dominated the market and held the highest revenue share of 79.6% in 2020. Therapeutic devices include, oral devices, nasal devices, and chin straps. Increasing awareness about these diseases, the rising availability of technologically advanced devices, the growing number of initiatives by local governments, and adherence to supporting treatment by patients are factors expected to provide lucrative opportunities for SA device manufacturers. This, in turn, is expected to drive the growth of the therapeutic devices segment over the forecast period.

However, the sleep apnea masks segment is expected to grow fast over the forecast period. The adoption of SA masks is increasing owing to the growing prevalence of SA comorbidities and the increasing adoption of CPAP machines for disease management. Technological advancements in SA devices are anticipated to drive the adoption of SA masks. For instance, in 2019, ResMed launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the U.S. with a newly designed nasal cradle cushion that sits just under the wearer’s nose.

North America dominated the sleep apnea devices market and accounted for the highest revenue share of 49.0%. The rising prevalence of respiratory disorders is leading to some or other form of sleeping disorder, which is driving the market. In addition, growing awareness about sleep apnea, a large patient pool, and the presence of international manufacturers are factors anticipated to strengthen the market share of this region. For instance, key players such as ResMed, Philips Respironics, and Somnetics International, Inc. have established a strong presence in the region and have also established strong distribution channels for easy supply of their products. Moreover, the number of therapeutic tests conducted in the region for confirming the presence of sleep apnea is rapidly rising, as many people are concerned about the health risks arising out of this condition.

However, in Asia Pacific, the market is anticipated to witness a significant growth rate during the forecast period. The rising geriatric population and increasing prevalence of lifestyle diseases are among the key factors driving the Asia Pacific market. For instance, according to the WHO, chronic respiratory diseases, diabetes, cardiovascular diseases, and cancer are some of the major conditions leading to the highest deaths in the region.

In addition, as per the IDF Diabetes Atlas 9th Edition, around 87.6 million people in the age group of 20 to 79 years suffer from diabetes in the South East Asia region. Such a rising prevalence of chronic conditions is expected to increase the adoption of sleep apnea devices in the region. As per a PubMed article, the prevalence of obstructive sleep apnea in Asia in middle-aged individuals ranges from 4.1% to 7.5% in males and 2.1% to 3.2% in females. As per an Asian Pacific Society of Respirology article, in May 2020, the prevalence in APAC countries ranged from 7.8% in Hong Kong to 77.2% in Malaysia, for mild sleep apnea cases. The research study highlighted names of four Asian countries among the top 10, with the highest prevalence of OSA. The countries with prevalence estimates for OSA with AHI > 15 events/hour were China (66 million patients, with a prevalence of 8.8%) and India (29 million, 5.4%).

Key Players

• ResMed
• Phillips Respironics
• Fisher & Paykel Healthcare Limited
• Curative Medical, Inc.
• Invacare Corporation
• Somnetics International, Inc.
• BMC Medical Co., Ltd.
• Natus Medical Incorporated
• SOMNOmedics GmbH
• Compumedics Limited
• Itamar Medical Ltd.
• Nihon Kohden Corporation

Market Segmentation

• Product Type Outlook
  • Diagnostic Devices
    • Actigraphs
    • Polysomnography (PSG) device
    • Respiratory Polygraphs
      • Cardiologists
      • ENT Specialists
      • Homecare Nurses
      • Sleep Physicians
      • Pulmonologists
      • Primary Care Physicians/General Physicians
      • Others
    • Pulse Oximeters
  • Therapeutic Devices
    • Positive Airway Pressure (PAP) Devices
      • CPAP
      • APAP
      • Bi-PAP
    • Oral Devices
    • Nasal Devices
    • Chin Straps
  • Sleep Apnea Masks
• Regional Outlook
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37522

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333